Eascra Biotech
PrivateLast Round
Grant
Mar 25, 2026
Total Funding Raised
$2.35M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Eascra Biotech is a biotechnology company that provides a nanomedicine platform for precision therapeutic delivery to hard-to-penetrate tissues like articular cartilage, kidneys, and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eascra Biotech Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Eascra Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 25, 2026 | ||||
| Accelerator | Jul 24, 2025 | ||||
| Grant | May 19, 2025 | ||||
| Grant | Apr 21, 2025 | ||||
| Grant | Mar 7, 2025 | ||||
Grant | Mar 7, 2025 |
Eascra Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MassVentures | Grant |
| United States Air Force | Grant |
| MassChallenge | Grant |
| TechConnect | Grant |
| Massachusetts Biomedical Initiatives | Accelerator |
| AFVentures | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 28, 2026
Grew 60% QoQ from 5 to 8 employees.
- Mar 10, 2026
Attended TechConnect World Innovation Conference and Expo in Raleigh, NC.
Eascra Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eascra Biotech's valuation, stock price, and market status.